Skip to content
10-Q

Quarterly Report

AngioDynamics, Inc. ANGO

0001628280-26-023008

← back to feed
Filed
Apr 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Mar 31, 2026 41.32M sh
Shares Diluted Q3 2026 · Feb 28, 2026 41.6M sh
Shares Diluted Q3 2026 · Feb 28, 2026 41.47M sh
Shares Diluted Q3 2026 · Feb 28, 2025 40.85M sh
Shares Diluted Q3 2026 · Feb 28, 2025 40.81M sh
Stock Repurchased Q3 2026 · Feb 28, 2026 $0
Stock Repurchased Q3 2026 · Feb 28, 2025 $1.67M
Capex Q3 2026 · Feb 28, 2026 $2.17M
Capex Q3 2026 · Feb 28, 2025 $3.69M
Operating Cash Flow Q3 2026 · Feb 28, 2026 −$14.36M
Operating Cash Flow Q3 2026 · Feb 28, 2025 −$28.94M
Cash And Equivalents Q3 2026 · Feb 28, 2026 $37.81M
Cash And Equivalents Q3 2026 · May 31, 2025 $55.89M
Stockholders Equity Q3 2026 · Feb 28, 2026 $173.36M
Stockholders Equity Q3 2026 · Nov 30, 2025 $176.33M
Stockholders Equity Q3 2026 · Aug 31, 2025 $178.86M
Stockholders Equity Q3 2026 · May 31, 2025 $182.97M
Stockholders Equity Q3 2026 · Feb 28, 2025 $185.87M
Stockholders Equity Q3 2026 · Nov 30, 2024 $186.77M
Stockholders Equity Q3 2026 · Aug 31, 2024 $196.58M
Stockholders Equity Q3 2026 · May 31, 2024 $205.59M
Current Liabilities Q3 2026 · Feb 28, 2026 $66.07M
Current Liabilities Q3 2026 · May 31, 2025 $76.2M
Total Liabilities Q3 2026 · Feb 28, 2026 $87.32M
Total Liabilities Q3 2026 · May 31, 2025 $97.17M
Current Assets Q3 2026 · Feb 28, 2026 $155.55M
Current Assets Q3 2026 · May 31, 2025 $168.32M
Total Assets Q3 2026 · Feb 28, 2026 $260.68M
Total Assets Q3 2026 · May 31, 2025 $280.14M
Eps Diluted Q3 2026 · Feb 28, 2026 −$0.19
Eps Diluted Q3 2026 · Feb 28, 2026 −$0.61
Eps Diluted Q3 2026 · Feb 28, 2025 −$0.11
Eps Diluted Q3 2026 · Feb 28, 2025 −$0.68
Eps Basic Q3 2026 · Feb 28, 2026 −$0.19
Eps Basic Q3 2026 · Feb 28, 2026 −$0.61
Eps Basic Q3 2026 · Feb 28, 2025 −$0.11
Eps Basic Q3 2026 · Feb 28, 2025 −$0.68
Sga Expense Q3 2026 · Feb 28, 2026 $10.72M
Sga Expense Q3 2026 · Feb 28, 2026 $33.43M
Sga Expense Q3 2026 · Feb 28, 2025 $10.49M
Sga Expense Q3 2026 · Feb 28, 2025 $31.86M
Rd Expense Q3 2026 · Feb 28, 2026 $7.08M
Rd Expense Q3 2026 · Feb 28, 2026 $21.27M
Rd Expense Q3 2026 · Feb 28, 2025 $6.91M
Rd Expense Q3 2026 · Feb 28, 2025 $19.63M
Net Income Q3 2026 · Feb 28, 2026 −$8.08M
Net Income Q3 2026 · Feb 28, 2026 −$25.34M
Net Income Q3 2026 · Nov 30, 2025 −$6.35M
Net Income Q3 2026 · Aug 31, 2025 −$10.9M
Net Income Q3 2026 · Feb 28, 2025 −$4.41M
Net Income Q3 2026 · Feb 28, 2025 −$27.94M
Net Income Q3 2026 · Nov 30, 2024 −$10.74M
Net Income Q3 2026 · Aug 31, 2024 −$12.8M
Operating Income Q3 2026 · Feb 28, 2026 −$12.95M
Operating Income Q3 2026 · Feb 28, 2026 −$29.73M
Operating Income Q3 2026 · Feb 28, 2025 −$9.97M
Operating Income Q3 2026 · Feb 28, 2025 −$34.17M
Gross Profit Q3 2026 · Feb 28, 2026 $41.48M
Gross Profit Q3 2026 · Feb 28, 2026 $128.12M
Gross Profit Q3 2026 · Feb 28, 2025 $38.86M
Gross Profit Q3 2026 · Feb 28, 2025 $115.49M
Cost Of Revenue Q3 2026 · Feb 28, 2026 $36.94M
Cost Of Revenue Q3 2026 · Feb 28, 2026 $105.45M
Cost Of Revenue Q3 2026 · Feb 28, 2025 $33.15M
Cost Of Revenue Q3 2026 · Feb 28, 2025 $96.85M
Revenue Q3 2026 · Feb 28, 2026 $78.42M
Revenue Q3 2026 · Feb 28, 2026 $233.57M
Revenue Q3 2026 · Feb 28, 2025 $72M
Revenue Q3 2026 · Feb 28, 2025 $212.34M